Billions in Pharma, but Still Dependent on Imports: How Long Will Kazakhstan Keep Buying Medicines From Abroad?
The share of domestically produced medicines in Kazakhstan remains low — about 15% — despite growth in production and state support for the industry, Orda.kz reports.
According to the Health Ministry’s response to Orda.kz, the share of Kazakhstani-made medicines stood at 15.1% in 2024. At the same time, the total volume of pharmaceutical production in the country continues to grow. By the end of 2025, it had increased by 8.2% to 191.1 billion tenge, up from 175.8 billion tenge a year earlier.
In the first two months of 2026, production reached 53.5 billion tenge.
Despite this, the market remains import-oriented. In 2025, the most in-demand drug was the anti-cancer medicine Keytruda, produced in Ireland.
The Health Ministry acknowledges that the development of domestic pharmaceuticals is being held back by dependence on imported raw materials and active substances, as well as strong competition from international companies. At the same time, officials say the industry has the potential to reduce import dependence. Among the priorities are production localization, technology transfer, and the use of Kazakhstani raw materials and personnel.
At the same time, the share of domestic medicines in procurement through the Single Distributor is gradually increasing. If in 2010 it stood at 15%, or 4.8 billion tenge, then by 2025 it had risen to 32%, or 137.5 billion tenge. Of that volume, 77% of purchases came under long-term contracts with Kazakhstani manufacturers.
To support the industry, a new mechanism has been introduced in the form of investment agreements. As of now, six such projects have been signed with companies including Nobel Almaty Pharmaceutical Factory and Khimpharm. The total volume of investment amounts to 316.3 billion tenge. The projects provide for the production of about 400 types of medicines and the creation of more than 1,100 jobs.
Original author: Elvira Ivannikova
Read also:
Latest news
- Ecology Ministry Explains 13 Million Tenge Fine For Picking Dandelions
- Kazakhstan Refineries Increase Oil Processing Depth To 90%
- High Rates No Longer Keep Kazakh Banks’ Profits Rising, Analysts Say
- Almaty Health Officials Prepare for Possible Hantavirus Cases
- Ministry Says Saiga Deaths Remain Within Natural Limits
- Kazakhstan Faces Shortage of Doctors and IT Specialists
- Kazakhstan Petition Calls for VAT Removal on Feminine Hygiene Products
- Kazakhstan to Publish Register of Convicted Economic Crime Offenders
- Kazakhstan’s Economy Grew 3.6% in Four Months
- Shymkent Colleges Used Fictitious Students to Steal Over 1.3 Billion Tenge
- Almaty Court Extends Chechen Activist’s Extradition Arrest
- Record Rainfall Hits Almaty
- Falling Caspian Sea Level Reshapes Northern Coastline
- Kazakhstan Says It Is Ready To Help Resolve Iran’s Nuclear Issue
- Pashinyan Explains Why He Will Skip The EAEU Summit In Astana
- Kazakhstan To Gradually Cut University Programs In Oversupplied Fields
- Kazakhstan Offers Indonesia A Route To Central Asia And Europe
- Kazakhstan Tightens Rules for Master Plans and Urban Development
- Kazakhstan Approves Rules for Digital Tenge Circulation
- Military Jets to Conduct Training Flights Over Astana
